Nontypable Haemophilus influenzae (NTHi) is a major cause of acute otitis media (AOM) accounting for 20-30% of all episodes. There is also evidence that NTHi is the most frequent pathogen in children with recurrent episodes of AOM. The extensive heterogeneity of outer membrane proteins has been an impediment to identifying effective vaccine candidates against NTHi. In animal models, membrane protein antigens tend to induce homologous, but not heterologous protection. To date, the PI's research on H. influenzae has exclusively focused on phylogenetic characterization of species natural population structure and its use to survey degree of conservation of potential outer membrane protein targets. Because few essential virulence factors have been identified in the pathogenesis of AOM caused by NTHi, the PI carried out a preliminary pilot study to test the hypothesis that sialic acid, a terminal sugar of NTHi lipopolysaccharicle, might be an essential virulence factor in AOM, analogous to the virulence role of sialic acid of LPS in gonococcal and meningococcal infections. These studies capitalized upon the availability of: (i) isogenic pairs of wild-type and LPS sialylation deficient mutants; (ii) the chinchilla animal model for experimental otitis media and (iii) the fine structural analysis of LPS, including data on organisms obtained ex-vivo from the animal model. This pilot study revealed attenuation of infection by the sialic acid deficient mutant strains compared to infection with wild-type organisms. This is consistent with prior studies showing that sialic acid deficient mutants of NTHi are relatively susceptible to complement mediated bactericidal killing by pooled human sera. The current R21 proposal aims to expand this preliminary evaluation of the role of sialic acid in the pathogenesis of AOM. It amalgamates population biology, a validated animal model of AOM, microbial genetics, and structural analysis to determine the role of sialic acid as virulence factor. These data will pave the way for further studies that could be supported by a future R01 application.

Agency
National Institute of Health (NIH)
Institute
National Institute on Deafness and Other Communication Disorders (NIDCD)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21DC005564-01
Application #
6494256
Study Section
Special Emphasis Panel (ZDC1-SRB-A (32))
Program Officer
Watson, Bracie
Project Start
2002-04-25
Project End
2004-03-31
Budget Start
2002-04-25
Budget End
2003-03-31
Support Year
1
Fiscal Year
2002
Total Cost
$80,500
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
005492160
City
Boston
State
MA
Country
United States
Zip Code
02118
Bouchet, Valerie; Huot, Heather; Goldstein, Richard (2008) Molecular genetic basis of ribotyping. Clin Microbiol Rev 21:262-73, table of contents
Leroy, Magali; Cabral, Howard; Figueira, Marisol et al. (2007) Multiple consecutive lavage samplings reveal greater burden of disease and provide direct access to the nontypeable Haemophilus influenzae biofilm in experimental otitis media. Infect Immun 75:4158-72
Cody, Alison J; Field, Dawn; Feil, Edward J et al. (2003) High rates of recombination in otitis media isolates of non-typeable Haemophilus influenzae. Infect Genet Evol 3:57-66
Bouchet, Valerie; Hood, Derek W; Li, Jianjun et al. (2003) Host-derived sialic acid is incorporated into Haemophilus influenzae lipopolysaccharide and is a major virulence factor in experimental otitis media. Proc Natl Acad Sci U S A 100:8898-903